ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Sjögren's Syndrome

Cold fingers? Is it primary or secondary Raynaud’s?

Raynaud’s phenomenon affects up to 5% of the general population, but for 37% of patients, it leads to connective tissue disease. In this slideshow, we compare primary and secondary Raynaud’s.  (Raynaud’s phenomenon, ©Twinschoice/Shutterstock.com)

Sjögren's Syndrome

©AndreyPopov/Shutterstock.com

The American College of Rheumatology and the European League Against Rheumatism have published an international set of classification criteria for primary Sjögren's syndrome.

©PhuShutter/Shutterstock.com

The Rheumatology Journal Club resumes its Twitter chat series this week with a focus on rheumatological immune-related adverse events in immunotherapy.

©AndreyPopov/Shutterstock.com

Clinicians should pay more attention to neurological signs in patients with high-activity primary Sjogren’s Syndrome or those with prior neurological involvements.

©vitstudio/Shuttersstock.com

Autoantibodies against carbamylated proteins in Sjögren’s syndrome could be used as a new biomarker.

B-cells that are active in lupus may also play a role in Sjögren’s syndrome. A new study finds that the same B-cell depleter drug, belimumab (Benlysta) approved for lupus, may also benefit Sjögren’s patients.

The increased risk for venous thromoboembolism after surgery among patients with rheumatic disease appears to trace to those conditions with a clotting component. However, joint surgery in general has a high risk of this complication.

Pages

Subscribe to Sjögren's Syndrome on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.